Achieve Life Sciences Inc (SP4P) - Total Liabilities

Latest as of September 2025: €18.43 Million EUR ≈ $21.54 Million USD

Based on the latest financial reports, Achieve Life Sciences Inc (SP4P) has total liabilities worth €18.43 Million EUR (≈ $21.54 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SP4P operating cash flow to assess how effectively this company generates cash.

Achieve Life Sciences Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how Achieve Life Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Check SP4P cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Achieve Life Sciences Inc Competitors by Total Liabilities

The table below lists competitors of Achieve Life Sciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Sailfish Royalty Corp V:FISH	Canada	CA$1.38 Million
Zinus Inc KO:013890	Korea	₩453.05 Billion
Acrow Ltd AU:ACF	Australia	AU$257.05 Million
CCK Consolidated Holdings Bhd KLSE:7035	Malaysia	RM149.64 Million
Virgin Galactic Holdings Inc NYSE:SPCE	USA	$627.65 Million
Grand Fortune Securities Co Ltd TWO:6026	Taiwan	NT$8.71 Billion
DingZing Advanced Materials Inc. TW:6585	Taiwan	NT$1.23 Billion
Hanmiglobal KO:053690	Korea	₩209.78 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Achieve Life Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Achieve Life Sciences Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.14	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.55	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Achieve Life Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Achieve Life Sciences Inc (2016–2024)

The table below shows the annual total liabilities of Achieve Life Sciences Inc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€17.73 Million ≈ $20.73 Million	-14.82%
2023-12-31	€20.82 Million ≈ $24.34 Million	-3.92%
2022-12-31	€21.67 Million ≈ $25.33 Million	+11.27%
2021-12-31	€19.47 Million ≈ $22.77 Million	+546.55%
2020-12-31	€3.01 Million ≈ $3.52 Million	-0.53%
2019-12-31	€3.03 Million ≈ $3.54 Million	-7.74%
2018-12-31	€3.28 Million ≈ $3.84 Million	+63.04%
2017-12-31	€2.01 Million ≈ $2.35 Million	-76.33%
2016-12-31	€8.50 Million ≈ $9.94 Million	--

About Achieve Life Sciences Inc

F:SP4P Germany Biotechnology

Market Cap

$224.05 Million

€191.64 Million EUR

Market Cap Rank

#16705 Global

#1578 in Germany

Share Price

€3.60

Change (1 day)

+0.56%

52-Week Range

€1.79 - €4.91

All Time High

€5709.00